Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

Clinical trial NCT04566432 · COMPLETED

Trial details

NCT number: NCT04566432
Sponsor: Geneplus-Beijing Co. Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Lung Neoplasms Lung Cancer, Nonsmall Cell Adenocarcinoma of Lung Squamous Cell Lung Cancer

Start date: 2020-07-01
Primary completion: 2025-12-31
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.